Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Participants With Traumatic Brain Injury: primary…
- Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults…
- Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals’ Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals’ Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®)…
- Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep: primary endpoint results, effect estimate with…
- Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials: primary endpoint…
- Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Long-term Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to
- Study to Assess the Safety and Effectiveness of the Penumbra System: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Safety and Effectiveness of the Penumbra System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms: primary endpoint results, effect…
- Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU: Complete Statistical AnalysisIndependent statistical analysis of Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe: Complete Statistical AnalysisIndependent statistical analysis of Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe: primary endpoint results, effect estimate with…
- Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.: Complete Statistical AnalysisIndependent statistical analysis of Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged…
- Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare Exposure of TA Following Administration of FX006 or TAcs in Patients With OA of the Shoulder or Hip: primary endpoint results, effect estimate with confidence…
- Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin): Complete Statistical AnalysisIndependent statistical analysis of Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare Palindrome vs. BioFlo DuraMax Dialysis Catheters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02796300).
- Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint…
- Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers: primary endpoint results, effect estimate with confidence interval,…
- Study to Demonstrate Cognitive Enhancing Effects of BF2.649: Complete Statistical AnalysisIndependent statistical analysis of Study to Demonstrate Cognitive Enhancing Effects of BF2.649: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00690274).
- Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS Glargine (G), United States (US)-Lantus®, and European Union (EU)-Lantus®: Complete Statistical AnalysisIndependent statistical analysis of Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS Glargine (G), United States (US)-Lantus®, and European Union (EU)-Lantus®: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid®: Complete Statistical AnalysisIndependent statistical analysis of Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-NovoRapid®: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA: Complete Statistical AnalysisIndependent statistical analysis of Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA: primary endpoint results, effect estimate with…
- Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate: Complete Statistical AnalysisIndependent statistical analysis of Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Determine Effects of Vesicare on Return to Continence Post – Radical Prostatectomy (Part II): Complete Statistical AnalysisIndependent statistical analysis of Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test): Complete Statistical AnalysisIndependent statistical analysis of Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test): Complete Statistical AnalysisIndependent statistical analysis of Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test): primary endpoint results, effect estimate with confidence interval,…
- Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information: Complete Statistical AnalysisIndependent statistical analysis of Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332: Complete Statistical AnalysisIndependent statistical analysis of Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03304054).
- Study to Evaluate an Influenza Vaccine Candidate: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate an Influenza Vaccine Candidate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00321373).
- Study to Evaluate ARD-101 in Adults With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate ARD-101 in Adults With Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05121441).
- Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain: Complete Statistical AnalysisIndependent statistical analysis of Study To Evaluate Efficacy And Safety Of An Additional Dose Of Celecoxib (YM177) In Patients With Post-Tooth Extraction Pain: primary endpoint results, effect estimate with confidence interval, sample-size…